1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, S; Burges, A; Chelariu-Raicu, A; Czogalla, B; Deuster, E; Hester, A; Hysenaj, I; Jeschke, U; Kahaly, M; Kolben, T; Kraus, F; Mahner, S; Mayr, D; Schmoeckel, E; Trillsch, F | 1 |
| Cong, Q; Gao, T; Jiang, W; Sun, M; Wang, Y; Xu, C; Yao, L; Yu, Y | 1 |
| Cai, Q; Jiang, W; Xu, C; Yu, Y; Zhang, M; Zhang, X; Zhu, Z | 1 |
| Cong, Q; Jiang, W; Li, MJ; Wang, YS; Xu, CJ; Ye, B | 1 |
| Herman, AG; Stockwell, BR | 1 |
| Chiang, KP; Cravatt, BF; Niessen, S; Saghatelian, A | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Ovary
| Article | Year |
|---|---|
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
Topics: Aged; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cyproheptadine; ErbB Receptors; Female; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prognosis; Receptors, G-Protein-Coupled; Signal Transduction; Treatment Outcome | 2021 |
Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Topics: Animals; Azepines; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Disease Progression; Female; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles; Tumor Microenvironment | 2018 |
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
Topics: Calcium; Cell Line, Tumor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Metalloproteases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Ovarian Neoplasms; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation | 2014 |
[Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Topics: Blood Platelets; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Migration Assays; Cyclic AMP Response Element-Binding Protein; Female; Humans; Imidazoles; In Vitro Techniques; Matrix Metalloproteinase 2; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, G-Protein-Coupled; Time Factors | 2011 |
Enzyme annotation with chemical tools.
Topics: Chromatography, High Pressure Liquid; Enzyme Activation; Enzyme Inhibitors; Enzymes; Female; Humans; Ketones; Lysophospholipids; Ovarian Neoplasms; Platelet Activating Factor; RNA Interference; Sensitivity and Specificity; Up-Regulation | 2006 |
An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling.
Topics: Carbamates; Carboxylic Ester Hydrolases; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Ketones; Lysophospholipids; Ovarian Neoplasms; Phospholipid Ethers; Platelet Activating Factor; RNA Interference; Sensitivity and Specificity; Signal Transduction; Sterol Esterase | 2006 |